Ebola virus is a severe, often fatal illness affecting humans and other primates, transmitted to people from wild animals (such as fruit bats) and then spreads in the human population through direct contact with the blood, secretions, organs, or other bodily fluids of infected people. The virus causes a hemorrhagic fever with symptoms ranging from fever and muscle pain to bleeding and organ failure. As of May 16, 2026, the WHO has declared the Bundibugyo virus Ebola outbreak in the Democratic Republic of Congo and Uganda a public health emergency of international concern (PHEIC), though it does not yet meet the criteria of a “pandemic emergency”. There is currently no cure, but early supportive care is lifesaving.
Key Takeaways
- What is Ebola: Severe viral hemorrhagic fever caused by orthoebolaviruses with fatality rates of 25-90
- Current Outbreak: 2026 Bundibugyo virus outbreak in the Democratic Republic of Congo and Uganda declared a WHO emergency
- How It Spreads: Direct contact with infected body fluids (not airborne), primarily in healthcare and family settings
- Symptoms: Fever, muscle pain, vomiting, diarrhea, followed by bleeding and organ dysfunction (incubation 2-21 days)
- Animal Origin: African fruit bats are believed to be the natural reservoir of orthoebolaviruses
- Death Rate: Average case fatality rate around 50%, ranging from 25-90% in past outbreaks
- No Approved Cure: No vaccine or treatment yet approved for Bundibugyo virus (current outbreak strain)
- Prevention: Early detection, isolation, strict infection control, and safe burial practices
What is the Ebola Virus?
Ebola virus is a member of the Filoviridae family, classified as an orthoebolavirus causing severe viral hemorrhagic fever in humans and primates. The disease was first identified in 1976 in simultaneous outbreaks near the Ebola River in Zaire (now the Democratic Republic of Congo) and in Sudan. Since then, there have been 17 documented Ebola outbreaks in the DRC alone, with the current 2026 outbreak being the latest global health emergency.
Types of Ebola Viruses
Six species of Ebola virus (orthoebolaviruses) have been identified:
- Zaire ebolavirus (EBOV) Most deadly; it caused the 2014-2016 West African epidemic
- Sudan ebolavirus (SUDV) was discovered in the 1976 Sudan outbreak; 50% fatality rate
- Bundibugyo ebolavirus (BDBV) Current 2026 outbreak strain (Congo/Uganda)
- Taï Forest ebolavirus Rare; discovered in Côte d’Ivoire chimpanzees (1994)
- Reston ebolavirus (RESTV) is found in primates and pigs; minimal human illness
- Bombali ebolavirus (BOMV) Discovered in bats (2018); pathogenicity in humans unknown
Current Emergency: The 2026 Bundibugyo virus outbreak is considered extraordinary because, unlike Ebola-Zaire strains, there are currently no approved Bundibugyo virus-specific therapeutics or vaccines.
Also read: Norovirus Infection: Symptoms, Treatment & Everything You Need to Know
What Causes Ebola? Animal Origins Explained
Fruit Bats: The Natural Reservoir
Fruit bats of the Pteropodidae family are thought to be natural hosts of the Orthoebolavirus. Three species of fruit bats showed evidence of symptomless infection – having Ebola-specific genetic sequences in their bodies or evidence of an immune response to Ebola, even though they did not exhibit signs of disease. These bats act as carriers without becoming sick.
How Ebola Spreads from Animals to Humans
The virus enters the human population when people have close contact with the blood, secretions, organs or other bodily fluids of infected animals such as fruit bats, chimpanzees, gorillas, monkeys, forest antelope or porcupines found ill or dead or in the rainforest. When an infected animal spreads the virus to a person, it is called a spillover event.
Common transmission routes from animals:
- Hunting and handling infected wildlife
- Consuming undercooked bushmeat from infected animals
- Contact with contaminated fruit in the forest
- Direct contact with infected bat saliva or feces
How Ebola Spreads: Person-to-Person Transmission
Transmission Routes
People can get infected with the virus from another person by direct contact (through broken skin or mucous membranes) with: the blood or body fluids of a person who is sick with or has died from Ebola disease; and surfaces and materials contaminated with these fluids.
Specific transmission methods include:
- Direct contact with blood or bodily fluids (highest risk)
- Contact with contaminated objects (needles, syringes, clothing, bedding)
- Contact with deceased bodies during burial ceremonies
- Semen from a person who recovered from Ebola disease through oral, vaginal, or anal sex (documented up to 15 months after clinical recovery)
- Breast milk from infected mothers
- Contact with placenta or amniotic fluid in pregnant women
How Ebola Does NOT Spread
Important: No evidence that orthoebolaviruses spread through contact with vaginal fluids from someone who has had Ebola disease or that mosquitoes or other insects can spread the viruses that cause Ebola disease. Ebola is not airborne it cannot be transmitted through coughing or sneezing.
High-Risk Groups
Health and care workers have frequently been infected while treating patients with Ebola disease through close contact with patients when infection control precautions are not strictly practiced. Family members caring for sick patients without proper protective equipment are also at high risk.
Ebola Virus Symptoms: What to Watch For
Incubation Period
The incubation period, or interval from infection to the onset of symptoms, ranges from 2 to 21 days, with symptoms typically beginning 8-10 days after exposure. An infected person cannot spread the disease until symptoms develop.
Early Symptoms (“Dry Stage”)
Symptoms of Ebola disease can be sudden and include fever, fatigue, malaise, muscle pain, headache and sore throat. These may resemble flu or other common illnesses.
Progressive Symptoms (“Wet Stage”)
As the disease progresses, additional symptoms emerge:
- Vomiting, diarrhoea, abdominal pain, rash, and symptoms of impaired kidney and liver functions
- Internal or external bleeding (oozing from gums, blood in stools)
- Organ failure
- Shock
Important Note: Despite a perception that bleeding is a common symptom, this is less frequent and can occur later in the disease.
Symptom Progression Timeline
| Day | Symptoms |
| 2-10 days | Fever, fatigue, muscle pain, headache, sore throat |
| 3-7 days later | Vomiting, diarrhea, rash, abdominal pain |
| 5-10 days later | Bleeding, organ dysfunction, shock |
Ebola Death Rate: How Deadly Is It?
Global Mortality Rates
The average Ebola disease case fatality rate is around 50%. Case fatality rates have varied from 25–90% in past outbreaks.
Mortality by strain:
- Zaire ebolavirus: Up to 90% (highest mortality)
- Sudan ebolavirus: 50-53%
- Bundibugyo virus (current outbreak): 30-50% case fatality rates in past BVD outbreaks
- Taï Forest ebolavirus: ~29%
- Reston ebolavirus: 0% in documented human cases
Current 2026 Outbreak Death Toll
As of May 16, 2026, eight laboratory-confirmed cases, 246 suspected cases and 80 suspected deaths have been reported in Ituri Province of the Democratic Republic of the Congo.
Also read: Measles Outbreak: Understanding The Global Spread And India’s Risk
2026 Ebola Outbreak: Current Status & Global Health Emergency
WHO Emergency Declaration
On May 16, 2026, the WHO Director-General determined that the Ebola disease caused by the Bundibugyo virus in the Democratic Republic of the Congo and Uganda constitutes a public health emergency of international concern (PHEIC).
Outbreak Timeline
- May 5, 2026: WHO alerted to high-mortality outbreak of unknown illness in Mongbwalu Health Zone, Ituri Province, DRC
- May 14, 2026: Laboratory confirmation of Bundibugyo virus in 8 of 13 samples
- May 15, 2026: DRC officially declared outbreak; Uganda reports first imported case in Kampala
- May 16, 2026: Uganda confirms second laboratory-confirmed case and one death
- May 17, 2026: WHO declares global public health emergency
Geographic Spread
Two laboratory confirmed cases (including one death) with no apparent link to each other have been reported in Kampala, Uganda, on 15 and 16 May 2026, among two individuals travelling from the Democratic Republic of the Congo. In the eastern DRC city of Goma, at least one Ebola case has been identified.
Congo Ebola Outbreak Details
Cases have been reported in at least three health zones, including Bunia, Rwampara and Mongbwalu, in Ituri Province of the Democratic Republic of the Congo. Unusual clusters of community deaths and healthcare worker infections have been documented.
Uganda Ebola Outbreak
In Uganda, two laboratory-confirmed cases, including one death, have been reported in the country’s capital, Kampala. Both cases involved individuals who had traveled from the DRC.
Ebola Risk in India: What’s the Current Status?
Currently, India has no confirmed Ebola cases. However, as a major international travel hub with connections to affected countries (DRC and Uganda), India is on WHO’s monitoring list for potential travel-associated cases.
Risk Factors for India
- International travelers from Congo and Uganda
- Healthcare workers treating potential Ebola patients
- Imported animals or animal products from outbreak regions
Indian Government Response
India’s health authorities are implementing surveillance protocols for travelers from affected areas and monitoring for any suspected cases.
Is Ebola Contagious? Infectiousness vs. Contagiousness
Understanding Ebola’s Transmission Nature
Ebola is extremely infectious but only moderately contagious. This distinction is critical:
- Infectious: Laboratory experiments on nonhuman primates suggest that even a single virus may be enough to trigger a fatal infection
- Moderately Contagious: The virus is not transmitted through the air, making it moderately contagious despite being extremely infectious
This means while a tiny amount can cause illness, transmission requires direct contact with bodily fluids it doesn’t spread through breathing air.
Also read: Why Diarrhea Cases Are Increasing in Children Under 5: What Recent Research Reveals
Ebola Diagnosis, Detection & Testing
Diagnostic Methods
- RT-PCR Testing: Polymerase chain reaction for detecting Ebola genetic material
- Antigen Detection: Rapid test for Ebola antigens in blood
- Blood Culture: Isolating the virus in the laboratory
- Imaging: CT scans and imaging to assess organ damage
Challenges in Diagnosis
It can be difficult to clinically distinguish Ebola from other infectious diseases such as malaria, typhoid fever and meningitis, making laboratory confirmation essential.
Does Ebola Have a Cure? Treatment Options
Current Treatment Status
Unlike Ebola virus disease caused by Zaire strain, there are currently no approved Bundibugyo virus-specific therapeutics or vaccines (the current 2026 outbreak strain).
FDA-Approved Treatments (Zaire Ebola Only)
For Zaire ebolavirus infection:
- Inmazeb™ (REGN-EB3) Monoclonal antibody therapy
- Ebanga™ (mAb114) Monoclonal antibody therapy
Supportive Care (Lifesaving Treatment)
Early intensive supportive care including rehydration and treatment of specific symptoms can improve survival. Seeking early care can be lifesaving.
Supportive treatments include:
- IV fluids and electrolyte replacement
- Blood pressure support
- Anti-nausea and anti-diarrhea medications
- Body Pain and fever management
- Treatment of secondary infections
Ebola Vaccine: Prevention & Development Status
Current Vaccine Situation
Unlike Ebola virus disease, there is no licensed vaccine or specific therapeutics against Bundibugyo virus.
Available Vaccines (Zaire Strain Only)
- Ervebo® Single-dose vaccine (most practical)
- Zabdeno and Mvabea® Two-dose vaccine regimen
Vaccine Development for Bundibugyo
Research and development activities are underway to advance potential candidate vaccines for the Bundibugyo strain, though none are currently licensed for use.
Prevention: How to Protect Yourself
For the General Public
- Avoid travel to active outbreak areas in Congo and Uganda if possible
- Practice standard hygiene (hand washing, food safety)
- Avoid contact with wildlife, bats, and bushmeat in outbreak regions
- If traveling from affected areas, self-monitor for 21 days
For Healthcare Workers
- Use proper personal protective equipment (PPE)
- Follow strict infection control protocols
- Practice safe needle handling and waste disposal
- Implement isolation procedures for suspected cases
For Communities in Outbreak Areas
- Practice safe burial practices (no direct contact with the deceased)
- Seek early medical care for fever and illness
- Support community engagement and public health measures
- Practice safe food preparation (avoid undercooked meat)
Also read: HPV Vaccination Drive Reaches 2,500+ Girls in Bengaluru: Why It Matters
When to Seek Medical Help
Seek immediate medical attention if you:
- Develop fever (especially if 38.5°C/101.5°F or higher)
- Have traveled to Congo, Uganda, or other affected areas in the past 21 days
- Had contact with someone who has Ebola
- Experience symptoms: muscle pain, headache, fatigue, vomiting, diarrhea, rash
Inform healthcare providers of:
- Recent travel history
- Contact with potentially infected individuals
- Contact with wildlife or bushmeat
- Timeline of symptom onset
Latest Ebola News & Updates
May 2026 WHO Global Health Emergency Declared
The Bundibugyo virus outbreak in the Democratic Republic of Congo and Uganda has been declared a public health emergency of international concern. The outbreak represents the 17th Ebola disease outbreak in the DRC since 1976.
Clinikk Health Hub Resources:
For the latest Ebola information, risk assessments, and travel health guidance, consult with Clinikk’s infectious disease specialists. We provide:
- Pre-travel health consultations for affected regions
- Post-travel health monitoring
- Fever diagnosis and management
- Infectious disease screening and testing
Key Takeaways: Ebola Virus Summary
- Ebola is a severe viral hemorrhagic fever with a 25-90% fatality rate
- Fruit bats are believed to be the natural animal reservoir
- Human-to-human transmission occurs only through direct contact with body fluids
- Incubation period is 2-21 days (average 8-10 days)
- The 2026 Bundibugyo outbreak is a WHO global health emergency
- No approved vaccine or treatment yet exists for the Bundibugyo virus
- Early supportive care is lifesaving and improves survival rates
- Prevention relies on strict infection control and safe practices
- Travelers from affected areas should self-monitor for 21 days
- Seek immediate medical care if symptoms develop
Clinikk Health Hub: Expert Infectious Disease Care
For Ebola screening, travel health services, or infectious disease consultation, Clinikk Health Hub is available 24/7 with locations across Delhi NCR, Mumbai, Bangalore, and Hyderabad. We offer virtual telemedicine consultations for those unable to visit in person. Our infectious disease specialists provide comprehensive services, including pre-travel health risk assessment, fever diagnosis and management, infectious disease screening, post-travel health monitoring, and isolation and infection control guidance. Whether you’re planning travel to affected regions, returning from an outbreak area, or need immediate evaluation for suspected symptoms, our team of experienced healthcare professionals is ready to help protect your health and prevent the spread of disease.
FAQs:
Q1: What is ebola?
A: Ebola is a severe viral hemorrhagic fever caused by orthoebolaviruses, affecting humans and other primates. It was first identified in 1976 and causes symptoms ranging from fever and muscle pain to bleeding and organ failure. The disease has fatality rates of 25-90%, averaging around 50%.
Q2: What is ebola virus disease?
A: Ebola virus disease (EVD) is another name for Ebola. It’s also called Ebola hemorrhagic fever (EHF). It’s a rare but life-threatening infection caused by contact with infected animals or people, primarily in Africa.
Q4: How does ebola spread?
A: Ebola spreads through direct contact with blood or body fluids of infected people, or contaminated objects like needles, clothing, or bedding. It can also spread through contact with infected animals or through burial rituals involving deceased bodies. It does NOT spread through air, water, food, or insects.
Q5: How ebola virus spread what are transmission routes?
A: The virus spreads through: direct contact with infected person’s blood/fluids, contact with contaminated objects, semen from recovered patients (up to 15 months), breast milk, and contact with deceased bodies. Healthcare workers and family caregivers are at highest risk due to close contact.
Q6: How is ebola transmitted?
A: Ebola is transmitted when the virus enters the body through broken skin or mucous membranes (eyes, nose, mouth) by direct contact with infected bodily fluids. It can also enter through contaminated needles, medical equipment, or surfaces.
Q7: Is Ebola contagious? Can it spread easily?
A: Ebola is “moderately contagious” while extremely infectious (a single virus can cause infection), it requires direct contact with bodily fluids for transmission. It’s not airborne. Most transmission occurs in healthcare settings or among family caregivers without proper protection.
Q8: Ebola spread by what’s the primary transmission method?
A: Ebola spreads primarily through direct contact with infected person’s blood and body fluids. Healthcare workers and family members are at highest risk due to close contact with sick patients without adequate protective equipment.
Q9: What are the early signs of Ebola symptoms?
A: Early symptoms include fever, fatigue, muscle pain, headache, and sore throat (appearing 2-10 days after exposure). These progress to vomiting, diarrhea, rash, and abdominal pain. Later symptoms include bleeding and organ dysfunction. Symptoms resemble flu initially, making early diagnosis challenging.
Q11: How is ebola diagnosed?
A: Diagnosis uses PCR (polymerase chain reaction) blood testing to detect Ebola genetic material. Antibody testing can also confirm recent infection. Patients are isolated and tested in specialized facilities due to high infectivity. Blood tests check for organ dysfunction (kidney, liver damage).
Q12: Ebola outbreak 2026, what’s the current status?
A: As of May 2026, WHO declared a public health emergency of international concern for the Bundibugyo virus outbreak in Democratic Republic of Congo and Uganda. Eight confirmed cases, 246 suspected cases, and 80 suspected deaths reported in Ituri Province. Two confirmed cases also in Kampala, Uganda.
Q13: Ebola outbreak who which countries are affected?
A: The current 2026 Bundibugyo virus outbreak affects Democratic Republic of Congo (Ituri Province: Bunia, Rwampara, Mongbwalu) and Uganda (Kampala). Neighboring countries are at high risk. This is the 17th Ebola outbreak in DRC since 1976.
Q14: Congo ebola what’s happening in the DRC?
A: The Democratic Republic of Congo is experiencing the 2026 Bundibugyo virus outbreak affecting Ituri Province with 8 confirmed, 246 suspected cases. Healthcare worker infections and community deaths have been reported. The outbreak was declared on May 15, 2026, with WHO emergency declaration on May 16.
Q15: Uganda ebola what’s the situation there?
A: Uganda confirmed two laboratory-confirmed Ebola cases in Kampala (May 15-16, 2026), including one death. Both cases involved individuals who traveled from the DRC. The cases had no apparent link to each other but represent international spread of the outbreak.
Q16: Ebola in india what’s the risk?
A: Currently, India has NO confirmed Ebola cases. However, as an international travel hub with connections to affected countries, India is on WHO’s monitoring list. Risk factors include travelers from Congo/Uganda and imported goods. India’s health authorities are implementing surveillance protocols.
Q17: Ebola death rate what are the fatality rates?
A: The average Ebola case fatality rate is around 50%. Rates vary by strain: Zaire (up to 90%), Sudan (50-53%), Bundibugyo (30-50%), Taï Forest (~29%). Death is typically due to shock from fluid loss, occurring 6-16 days after symptom onset. Early supportive care significantly improves survival.
Q19: Ebola virus death rate by strain?
A: Death rates by strain: Zaire ebolavirus (up to 90%), Sudan ebolavirus (50-53%), Bundibugyo virus (30-50%), Taï Forest ebolavirus (~29%), Reston ebolavirus (0% in humans). The 2026 outbreak strain (Bundibugyo) has lower mortality than Zaire but no approved treatment.
Q20: Ebola causes what death?
A: Ebola causes death through: hemorrhagic shock (fluid loss), organ failure (kidney, liver, heart), secondary infections, and multi-organ dysfunction. The virus damages blood vessel integrity, causing internal/external bleeding and fluid loss. Supportive care (IV fluids, organ support) is critical for survival.
Q22: The Ebola virus is caused by which animal? How does spillover happen?
A: Ebola spills over to humans from infected animals through: hunting and handling wildlife, consuming undercooked bushmeat from infected primates/antelopes, contact with fruit contaminated by bat saliva/feces, or direct contact with infected animals. Once in humans, it spreads person-to-person through body fluids.
Q25: Does ebola have a cure?
A: Currently, there is NO cure for Ebola. However, early intensive supportive care (IV fluids, electrolytes, symptom management, organ support) significantly improves survival. For Zaire ebolavirus specifically, two FDA-approved monoclonal antibody treatments (Inmazeb and Ebanga) are available. For Bundibugyo virus (current outbreak), no approved treatments exist yet
Q28: Ebola vaccine is one available?
A: For Zaire ebolavirus: YES Ervebo® (single dose) and Zabdeno®/Mvabea® (two doses) are FDA-approved vaccines. For Bundibugyo virus (current 2026 outbreak): NO approved vaccine yet, though candidates are in development. Vaccination is recommended for healthcare workers, laboratory staff, and people at high risk of exposure.
Q29: Is ebola vaccine available in India?
A: Currently, Ebola vaccines are not widely available in India. India’s health authorities are monitoring the situation. Vaccines are primarily available for high-risk groups (healthcare workers in outbreak areas, laboratory staff) in developed countries. In case of outbreak spread to India, WHO would coordinate vaccine distribution.
